PolyPeptide Group Appoints Raymond De Vré as new CEO

17.02.2021 - PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate on her role on the Board of Directors.

De Vré will join the group as CEO elect on April 1, 2021 and will work alongside Salik during a transition period prior to taking up his role as CEO over the course of the summer. Salik will remain a member of the Executive Committee until the summer of 2021.

During the past 8 years, De Vré has worked at Dr. Reddy's Laboratories, where he currently is a member of the Management Council and Global Head of Biologics. Prior to this, he spent 15 years with McKinsey, where he was a Partner advising pharmaceutical, biotech and specialty chemical companies in Europe, the US and India. De Vré is a Belgian national and holds a master’s degree in engineering from Université Libre de Bruxelles (ULB) as well as a PhD in applied physics from Stanford University.